Craig Vargo

459 total citations
20 papers, 340 citations indexed

About

Craig Vargo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Craig Vargo has authored 20 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in Craig Vargo's work include Cancer Treatment and Pharmacology (5 papers), HER2/EGFR in Cancer Research (5 papers) and Advanced Breast Cancer Therapies (4 papers). Craig Vargo is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), HER2/EGFR in Cancer Research (5 papers) and Advanced Breast Cancer Therapies (4 papers). Craig Vargo collaborates with scholars based in United States, Switzerland and Italy. Craig Vargo's co-authors include Romano Danesi, David Venzon, Douglas K. Price, Tristan M. Sissung, Jürgen Venitz, Lokesh Jain, William D. Figg, Michael Berger, Bhuvaneswari Ramaswamy and Akshara Singareeka Raghavendra and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

Craig Vargo

20 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Craig Vargo United States 8 172 114 102 76 37 20 340
Luciano Wannesson Switzerland 14 235 1.4× 112 1.0× 174 1.7× 67 0.9× 16 0.4× 31 440
Tuan S. Nguyen United States 10 150 0.9× 133 1.2× 80 0.8× 35 0.5× 26 0.7× 19 338
Sally L. George United Kingdom 10 115 0.7× 107 0.9× 62 0.6× 52 0.7× 23 0.6× 23 322
Pierre‐Marie Morice France 7 243 1.4× 97 0.9× 39 0.4× 44 0.6× 22 0.6× 21 382
Yasuhiro Arakawa Japan 11 159 0.9× 150 1.3× 86 0.8× 94 1.2× 26 0.7× 37 380
Fazıl Aydin Türkiye 11 132 0.8× 69 0.6× 88 0.9× 38 0.5× 37 1.0× 32 345
Yoichi Nishii Japan 13 97 0.6× 120 1.1× 269 2.6× 85 1.1× 20 0.5× 43 463
Zijun Zhen China 12 155 0.9× 103 0.9× 60 0.6× 44 0.6× 18 0.5× 62 389
Arzu Oğuz Türkiye 9 205 1.2× 39 0.3× 60 0.6× 63 0.8× 23 0.6× 36 310
Fernando Cotait Maluf Brazil 11 107 0.6× 70 0.6× 140 1.4× 42 0.6× 38 1.0× 38 368

Countries citing papers authored by Craig Vargo

Since Specialization
Citations

This map shows the geographic impact of Craig Vargo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Vargo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Vargo more than expected).

Fields of papers citing papers by Craig Vargo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig Vargo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Vargo. The network helps show where Craig Vargo may publish in the future.

Co-authorship network of co-authors of Craig Vargo

This figure shows the co-authorship network connecting the top 25 collaborators of Craig Vargo. A scholar is included among the top collaborators of Craig Vargo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig Vargo. Craig Vargo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goldstein, Daniel A., Dionisia Quiroga, Mahmoud Kassem, et al.. (2023). The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer. Oncology and Therapy. 11(3). 361–374. 1 indexed citations
2.
Berger, Michael, et al.. (2023). Effect of Concurrent Proton Pump Inhibitors With Palbociclib Tablets for Metastatic Breast Cancer. Clinical Breast Cancer. 23(6). 658–663. 8 indexed citations
3.
4.
5.
Berger, Michael, et al.. (2021). Comparison of subsequent infusion hypersensitivity reactions to paclitaxel using two different infusion strategies. Supportive Care in Cancer. 29(8). 4423–4429. 3 indexed citations
6.
Palettas, Marilly, Julie Stephens, Michael Berger, et al.. (2020). Efficacy of different dosing schedules of capecitabine for metastatic breast cancer: a single-institution experience. Investigational New Drugs. 38(5). 1605–1611. 2 indexed citations
7.
Berger, Michael, Craig Vargo, Junan Li, et al.. (2019). Pathological complete response rates with pertuzumab-based neoadjuvant chemotherapy in breast cancer: A single-center experience. Journal of Oncology Pharmacy Practice. 26(3). 572–579. 4 indexed citations
8.
Berger, Michael, Maryam B. Lustberg, Raquel E. Reinbolt, et al.. (2019). Progression-Free Survival for Real-World Use of Palbociclib in Hormone Receptor-Positive Metastatic Breast Cancer. Clinical Breast Cancer. 20(1). 33–40. 35 indexed citations
9.
Berger, Michael, et al.. (2018). Time to treatment failure of palbociclib and letrozole as second-line therapy or beyond in hormone receptor-positive advanced breast cancer. Journal of Oncology Pharmacy Practice. 25(6). 1374–1380. 2 indexed citations
10.
Reinbolt, Raquel E., Michael V. Knopp, Norman Williams, et al.. (2018). Abstract OT2-05-03: Does minocycline mitigate chemotherapy induced neuroinflammation? A phase II randomized placebo controlled study. Cancer Research. 78(4_Supplement). OT2–5. 1 indexed citations
11.
Hill, Jordan, et al.. (2018). Safety of dose-reduced pemetrexed in patients with renal insufficiency. Journal of Oncology Pharmacy Practice. 25(5). 1125–1129. 4 indexed citations
12.
Vargo, Craig, et al.. (2016). Learning to Sew: A Student Pharmacist’s Service-Learning Experience. Purdue e-Pubs (Purdue University). 3(1). 2 indexed citations
13.
Vargo, Craig, Michael Berger, Gary Phillips, & Ewa Mrózek. (2016). Occurrence and characterization of everolimus adverse events during first and subsequent cycles in the treatment of metastatic breast cancer. Supportive Care in Cancer. 24(7). 2913–8. 3 indexed citations
14.
Dzimitrowicz, Hannah, Michael Berger, Craig Vargo, et al.. (2016). T-DM1 Activity in Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancers That Received Prior Therapy With Trastuzumab and Pertuzumab. Journal of Clinical Oncology. 34(29). 3511–3517. 54 indexed citations
15.
Vargo, Craig, Marlo Blazer, Joshua Reardon, Martha Gulati, & Tanios Bekaii‐Saab. (2015). Successful Completion of Adjuvant Chemotherapy in a Patient With Colon Cancer Experiencing 5-Fluorouracil–Induced Cardiac Vasospasm. Clinical Colorectal Cancer. 15(2). e61–e63. 6 indexed citations
16.
Berger, Michael, Craig Vargo, Gary Phillips, et al.. (2014). Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction. Supportive Care in Cancer. 23(7). 2019–2024. 19 indexed citations
17.
Vargo, Craig, et al.. (2014). An Antimicrobial Stewardship Program's Real‐World Experience with Fidaxomicin for Treatment of Clostridium difficile Infection: A Case Series. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 34(9). 901–909. 13 indexed citations
18.
Kiel, Patrick J., et al.. (2012). Possible Correlation of Sirolimus Plasma Concentration with Sinusoidal Obstructive Syndrome of the Liver in Patients Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 32(5). 441–445. 7 indexed citations
19.
Kiel, Patrick J., Iftekhar Kalsekar, Craig Vargo, et al.. (2010). Prophylaxis with Sirolimus and Tacrolimus ± Antithymocyte Globulin Reduces the Risk of Acute Graft-versus-Host Disease without an Overall Survival Benefit Following Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 17(6). 916–922. 27 indexed citations
20.
Jain, Lokesh, Craig Vargo, Romano Danesi, et al.. (2009). The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors. Molecular Cancer Therapeutics. 8(9). 2496–2508. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luciano Wannesson Breakdown of academic impact, for papers by Tuan S. Nguyen Breakdown of academic impact, for papers by Sally L. George Breakdown of academic impact, for papers by Pierre‐Marie Morice Breakdown of academic impact, for papers by Yasuhiro Arakawa Breakdown of academic impact, for papers by Fazıl Aydin Breakdown of academic impact, for papers by Yoichi Nishii Breakdown of academic impact, for papers by Zijun Zhen Breakdown of academic impact, for papers by Arzu Oğuz Breakdown of academic impact, for papers by Fernando Cotait Maluf
Rankless by CCL
2026